Yahoo! Finance: Commodity News
LONDON & PHILADELPHIA & CARLSBAD, Calif.----GlaxoSmithKline and Regulus Therapeutics LLC today announced a worldwide strategic alliance to discover, develop and market novel microRNA-targeted therapeutics to treat inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.
complete story here...
Highly recommended services:
Macro Millionaire - World-class advisory from "Mad Hedge Fund Trader" John Thomas, terrific record of wins
Crash Trader - Greg Roy, the "Rain Man" trader, protects you from market crashes by playing the short side
Biotech Breakout Trader - Mark Messier profits from biotech stocks, by taking advantage of "stupid" traders